510(k) K223643
K223643 is an FDA 510(k) premarket notification submitted by Promisemed Hangzhou Meditech Co., Ltd. for the device "Verifine® Ease Lancing Device, Verifine® Lancing Device". The FDA issued a decision of Substantially Equivalent on Feb 21, 2023. The device falls under product code QRL (Multiple Use Blood Lancet For Single Patient Use Only), a Class II device regulated under 21 CFR 878.4850. Promisemed Hangzhou Meditech Co., Ltd. has 35 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 21, 2023
- Date Received
- Dec 6, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Multiple Use Blood Lancet For Single Patient Use Only
- Device Class
- Class II
- Regulation Number
- 878.4850
- Review Panel
- SU
- Submission Type
- 510(k)
A multiple use capable blood lancet intended for use on a single patient that is comprised of a single use blade attached to a solid, reusable base that is used to puncture the skin to obtain a drop of blood for diagnostic purposes.
Need the full FDA record for Promisemed Hangzhou Meditech Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.